你即將離開本站

並前往https://www.npr.org/2023/01/31/1152907937/after-more-than-20-years-a-major-arthritis-drug-is-about-to-face-cheaper-competi

After more than 20 years, a major arthritis drug is about to face ...

... it's supposed to go generic and the price is supposed to go down. For blockbuster arthritis drug Humira, that hasn't happened — until now.

確定！ 回上一頁

查詢 「Humira stock」的人也找了：

  1. AbbVie
    2.
  2. Amgen stock
    3.
  3. Adm stock
    4.
  4. abbvie產品
    5.
  5. MO stock
    6.
  6. BMY stock
    7.
  7. Novartis stock
    8.
  8. J.P. stock
    9.